Tech Company Financing Transactions
LePure Biotech Funding Round
LePure Biotech closed a Series C investment round on 1/17/2023. Investors included General Atlantic, Goldman Sachs and Novo Holdings.
Transaction Overview
Company Name
Announced On
1/17/2023
Transaction Type
Venture Equity
Amount
Unknown
Round
Series C
Investors
Proceeds Purpose
The company intends to use the funds to accelerate product innovation, promote overseas expansion, and enhance its competitiveness in global industrial chain.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2200 West Park Dr 300
Westborough, MA 01581
USA
Westborough, MA 01581
USA
Phone
Website
Email Address
Overview
LePure Biotech was established in 2011. It pioneered localization of single-use solutions for biopharmaceutical industry in China. LePure Biotech has comprehensive capabilities in R&D, manufacturing, and commercial operation. LePure Biotech is a customer centric company with commitment to high quality and continuous improvement. Driven by technology innovation, the company wants to be the most reliable partner of global biopharma. It empowers Biopharm customers with high quality and innovative bioprocess solutions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Feng Wang
Browse more venture capital transactions:
Prev: 1/17/2023: Intella X venture capital transaction
Next: 1/17/2023: Sublime Systems venture capital transaction
Share this article
About Database of VC Transactions
We report on funding rounds that are announced publicly. VC investment data records reported here are derived from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs